1. Fatal disseminated strongyloidiasis after kidney transplantation
- Author
-
Carla Juliana Araújo Ferreira, Francisco Gilberto Pinheiro, Patrícia Holanda Almeida, Débora Albuquerque da Silva, Antônio Fernando Coutinho, Raimundo Pires Maia, Geraldo Bezerra da Silva Junior, Leila Silveira Vieira da Silva, Valencio Pereira de Carvalho, and Rodrigo Alves de Oliveira
- Subjects
Male ,Microbiology (medical) ,medicine.medical_specialty ,Pediatrics ,lcsh:Arctic medicine. Tropical medicine ,lcsh:RC955-962 ,Strongyloides stercoralis ,Albendazole ,Immunocompromised Host ,Fatal Outcome ,Postoperative Complications ,Transplante renal ,medicine ,Animals ,Humans ,Kidney transplantation ,Immunosuppression Therapy ,biology ,business.industry ,Middle Aged ,medicine.disease ,biology.organism_classification ,Kidney Transplantation ,Surgery ,Disseminated strongyloidiasis ,Kidney transplant recipient ,Infectious Diseases ,Strongyloidiasis ,Parasitic disease ,Parasitology ,business ,Estrongiloidíase ,medicine.drug - Abstract
Disseminated strongyloidiasis (DS) is a rare and severe parasitic disease that is difficult to recognize and affects immunocompromised individuals. We report the case of a kidney transplant recipient who presented with DS despite prophylaxis with albendazole. We have discussed the need for better prophylactic strategies and for a higher degree of suspicion in order to diagnose DS.
- Published
- 2012